News & Insights
Walsworth publishes its 2020 Year In Review Life Sciences Update. Stay up-to-date with our discussion of recent drug litigation, including Lipitor and Lexapro, device litigation, including pelvis mesh and breast implants, talc, opioids, and trends in life sciences, including CBD, COVID-19 updates and trials, and pending U.S. Supreme Court jurisdictional litigation.
Click here to read the full report.
For more information, please contact Katie Stricklin.